DANIEL RINCON PEREZ: Open Payments
NPI 1851027528 · ANKENY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $190 |
| ABBVIE INC. | 6 | $157 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $110 |
| GENZYME CORPORATION | 1 | $80 |
Products named: REXULTI, JARDIANCE, QULIPTA, AIRSUPRA, Ozempic, Wegovy, DUPIXENT, UBRELVY.
Industry payments across IA — which companies pay providers there.
